- Home
- GROY vs GNFT Comparison
GROY vs GNFT Comparison
Compare GROY & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- GNFT
- Stock Information
- Founded
- GROY 2020
- GNFT 1999
- Country
- GROY Canada
- GNFT France
- Employees
- GROY N/A
- GNFT N/A
- Industry
- GROY
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GROY
- GNFT Health Care
- Exchange
- GROY Nasdaq
- GNFT Nasdaq
- Market Cap
- GROY 206.6M
- GNFT 189.6M
- IPO Year
- GROY 2021
- GNFT 2019
- Fundamental
- Price
- GROY $1.20
- GNFT $3.80
- Analyst Decision
- GROY Strong Buy
- GNFT Strong Buy
- Analyst Count
- GROY 4
- GNFT 1
- Target Price
- GROY $3.25
- GNFT $13.00
- AVG Volume (30 Days)
- GROY 996.4K
- GNFT 9.8K
- Earning Date
- GROY 11-04-2024
- GNFT 09-19-2024
- Dividend Yield
- GROY N/A
- GNFT N/A
- EPS Growth
- GROY N/A
- GNFT N/A
- EPS
- GROY N/A
- GNFT 0.47
- Revenue
- GROY $7,764,000.00
- GNFT $86,225,222.00
- Revenue This Year
- GROY $289.17
- GNFT $155.44
- Revenue Next Year
- GROY $102.86
- GNFT N/A
- P/E Ratio
- GROY N/A
- GNFT $7.53
- Revenue Growth
- GROY 197.02
- GNFT 175.45
- 52 Week Low
- GROY $1.17
- GNFT $3.31
- 52 Week High
- GROY $2.21
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- GROY 36.60
- GNFT 29.24
- Support Level
- GROY $1.17
- GNFT $3.63
- Resistance Level
- GROY $1.33
- GNFT $3.88
- Average True Range (ATR)
- GROY 0.04
- GNFT 0.10
- MACD
- GROY -0.00
- GNFT 0.02
- Stochastic Oscillator
- GROY 12.50
- GNFT 15.30
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and streaming company. It offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.